Skip to main content
NCBI home page
Theranostics logoLink to Theranostics
. 2022 Mar 6;12(6):2637–2638. doi: 10.7150/thno.72333

Myocardium-targeted transplantation of PHD2 shRNA-modified bone mesenchymal stem cells through ultrasound-targeted microbubble destruction protects the heart from acute myocardial infarction: Erratum

Zhenxing Sun 1,2,*, Yuji Xie 1,2,*, Robert J Lee 3, Yihan Chen 1,2, Qiaofeng Jin 1,2, Qing Lv 1,2, Jing Wang 1,2, Yali Yang 1,2, Yuman Li 1,2, Yu Cai 1,2, Rui Wang 1,2, Zhengyang Han 1,2, Li Zhang 1,2,✉, Mingxing Xie 1,2,✉
PMCID: PMC8965490  PMID: 35401840

The authors apologize that the original version of this paper unfortunately contained two incorrect figures and a terminology error due to negligence in drafting and proofreading. Firstly, in Section A of Figure 2, the DAPI and Merge images of the control group were not presented correctly. Secondly, Section B and Section C of Figure 7 were reversely marked. In addition, the term MI-LV-shPHD2-BMSC in the last paragraph of the Results section should be “MI-LV-GFP-BMSC” (Page 4977).

The authors apologize for any inconvenience these errors may have caused. Luckily they have no influence on the conclusion drawn by the study. The correct figures are shown below.

Figure 1.

Figure 1

Open in a new tab

Corrected figure for original Figure 2A.

Figure 2.

Figure 2

Open in a new tab

Corrected figure for original Figure 7.

References

  • 1.Sun Z, Xie Y, Lee RJ, Chen Y, Jin Q, Lv Q, Wang J, Yang Y, Li Y, Cai Y, Wang R, Han Z, Zhang L, Xie M. Myocardium-targeted transplantation of PHD2 shRNA-modified bone mesenchymal stem cells through ultrasound-targeted microbubble destruction protects the heart from acute myocardial infarction. Theranostics. 2020;10(11):4967–4982. doi: 10.7150/thno.43233. doi:10.7150/thno.43233. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Theranostics are provided here courtesy of Ivyspring International Publisher

RESOURCES